Back to Ally Bridge Group (NY) LLC
Q2 2026 13F filing
Updated 28 days ago25 disclosed positions worth $113.1M
Portfolio value
$113.1M
Total holdings
25
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-08-14
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | D DFTX DEFINIUM THERAPEUTICS INC | $18.8M | 400.0K | 16.64% | — |
| 2 | A AAVXF ABIVAX SA | $16.7M | 125.0K | 14.73% | — |
| 3 | N NERV MINERVA NEUROSCIENCES INC | $12.1M | 2.18M | 10.68% | — |
| 4 | P PMN PROMIS NEUROSCIENCES INC | $8.2M | 620.3K | 7.22% | — |
| 5 | ? N/A FIRST TRACKS BIOTHERAPEUTICS | $5.7M | 284.3K | 5.06% | — |
| 6 | A AXSM AXSOME THERAPEUTICS INC | $4M | 16.5K | 3.57% | — |
| 7 | A ASH ASSEMBLY BIOSCIENCES INC | $3.8M | 140.0K | 3.40% | — |
| 8 | ? N/A WHITEHAWK THERAPEUTICS INC | $3.7M | 817.9K | 3.31% | — |
| 9 | E EWTX EDGEWISE THERAPEUTICS INC | $3.4M | 83.3K | 2.99% | — |
| 10 | ? N/A CLIMB BIO INC | $3.2M | 249.2K | 2.87% | — |
| 11 | K KURA KURA ONCOLOGY INC | $3.2M | 290.0K | 2.81% | — |
| 12 | C CTMX CYTOMX THERAPEUTICS INC. | $2.9M | 775.0K | 2.57% | — |
| 13 | A AVTX AVALO THERAPEUTICS INC | $2.8M | 150.0K | 2.45% | — |
| 14 | ? N/A PALISADE BIO INC | $2.6M | 1.23M | 2.27% | — |
| 15 | S SLDB SOLID BIOSCIENCES INC | $2.6M | 256.0K | 2.26% | — |
| 16 | ? N/A AN2 THERAPEUTICS INC | $2.5M | 526.3K | 2.25% | — |
| 17 | U URGN UROGEN PHARMA LTD | $2.5M | 69.2K | 2.25% | — |
| 18 | ? N/A PERSPECTIVE THERAPEUTICS INC | $2.5M | 744.0K | 2.24% | — |
| 19 | I IDYA IDEAYA BIOSCIENCES INC | $2.5M | 67.5K | 2.22% | — |
| 20 | I IVEVF INVENTIVA SA | $2.4M | 634.8K | 2.12% | — |
| 21 | A ALMS ALUMIS INC | $2.2M | 76.5K | 1.90% | — |
| 22 | O OVID OVID THERAPEUTICS INC | $1.7M | 624.6K | 1.49% | — |
| 23 | E EPRX EUPRAXIA PHARMACEUTICALS INC | $1.7M | 252.2K | 1.47% | — |
| 24 | ? N/A IBIO INC | $683K | 390.1K | 0.60% | — |
| 25 | T TRAW TRAWS PHARMA INC | $663K | 786.2K | 0.59% | — |